Low levels of coagulation inhibitors: a high-risk thrombotic factor in thalassemic patients

ConclusionAccording to the findings of present work, significant changes in the PRC, PRS and AT-III which could be observed in multi transfused β-TM patients may attribute as critical risk factors for the development of upcoming thromboembolic events in their future life.

Source: Revista Clinica Espanola - October 26, 2019 Category: Internal Medicine Source Type: research